Disorders A - Z:   A    B   C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z

Skip secondary menu

Office of Translational Research


Welcome to the NINDS Office of Translational Research (OTR). Our mission is to accelerate the preclinical discovery and development of new therapeutic interventions for neurological disorders. To facilitate this process, OTR offers a variety of funding opportunities and programs. Researchers looking for funding should click on the Funding and Programs for Researchers tab, which shows programs based on the type of therapeutic approach and stage of project they support. Investigators and potential investors interested in our active grant portfolio or in partnering should click on the Active Projects for Partnering tab. Are you new to translational research? If so, click on the decision tree for therapeutic development to explore funding opportunity pathways.

  • carousel_create-imagemap
  • SBIR/STTR Success Stories
  • carousel blueprint banner
  • carousel counteract banner
  • carousel small business banner
  • NINDS Translational Programs: Priming the Pump of Neurotherapeutics Discovery and Development
  • banner controller



OTR Attended Events

There are currently no events.

More Events »



Are you developing a small molecule
Are you developing a biologic
Are you developing a therapeutic device

Plus/Minus Sign   

Office of Translational Research Program Staff

Karrah Benson, B.S.
Program Coordinator
Anticonvulsant Screening Program (ASP)

Chris Boshoff, Ph.D.
Scientific Project Manager
Cooperative Program in Translational Research and CREATE Bio

Tracy Chen, Ph.D., D.A.B.T.
Scientific Project Manager
Anticonvulsant Screening Program (ASP)

Charles Cywin, Ph.D.
Project Manager
Blueprint Neurotherapeutics Network

Rebecca Farkas, Ph.D.
Program Director
Blueprint Neurotherapeutics Network, Medicinal Chemistry, Roadmap Molecular Libraries

Stephanie Fertig, MBA
Research Project Manager
Small business (SBIR, STTR) and CREATE Devices

Adrienne Ivory, M.S.
Program Analyst
Blueprint Neurotherapeutics Network

David Jett, Ph.D.
Program Director
Countermeasures (CounterACT) Programs, Neurotoxicology, Roadmap Molecular Libraries

John Kehne, Ph.D.
Program Director
Anticonvulsant Screening Program (ASP)

Linda McGavern, Ph.D.
Project Manager
Cooperative Program in Translational Research and CREATE Bio

Margaret Ochocinska, Ph.D.
Health Program Specialist
Anticonvulsant Screening Program (ASP), Countermeasures (CounterACT) Programs

Mary Ann Pelleymounter, Ph.D.
Scientific Project Manager, IGNITE Program

Shamsi Raeissi, Ph.D.
Scientific Project Manager
Anticonvulsant Screening Program (ASP)

Rajesh Ranganathan, Ph.D.
Associate Director

Rebecca Roof, Ph.D.
Health Program Specialist
Small Business (SBIR, STTR), IGNITE Program

Amir Tamiz, Ph.D.
Program Manager
Blueprint Neurotherapeutics Program, IGNITE Program

Christina Vert, M.S.
Health Program Specialist
Cooperative Program in Translational Research and CREATE Bio

Hao Wang, Ph.D.
Program Director
Cooperative Program in Translational Research and CREATE Bio

David Yeung, Ph.D.
Scientific Project Manager
Countermeasures Against Chemical Threats(CounterACT) Programs